SMAD7 and melanoma: Furthermore, high SMAD7 expression independently predicted unfavourable outcomes: melanoma-specific survival (hazard ratio = 3.16, p < 0.001) and recurrence-free survival (hazard ratio = 2.88, p < 0.001).